drugset / Trial / NCT07002749

ROLE OF PROPHYLACTIC TRANEXAMIC ACID IN PREVENTION OF POST-PARTUM HEMORRHAGE IN ELLSCS

NCT07002749

Phase 1 Not yet recruiting 104 enrolled Patel Hospital, Pakistan
RandomizedParallel-groupTriple-blindTreatment

Summary

IN THIS STUDY WOMEN UNDER GOING ELLSCS WOULD BE DIVIDED INTO TWO GROUPS , ONE GROUP WOULD BE GIVEN TRANEXAMIC ACID WHILE THE OTHER WOULD BE GETTING PLACEBO PROPHYLACTICALLY TO SEE THE EFFECT OF TRANEXAMIC ACID IN PREVENTING PPH. THIS IS A RANDOMIZED CONTROLLED TRIAL. THE SAMPLING TECHNIQUE WOULD BE NON-PROBABILITY TECHNIQUE RANDOMIZATION WOULD BE DONE VIA BALLOTING METHOD.

Timeline

Start
2025-06-01
Primary completion
2025-06-01
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule

Indications

No indication recorded.